Strandberg Karin, Palmberg Lena, Larsson Kjell
Lung and Allergy Research, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
J Asthma. 2008 Apr;45(3):201-3. doi: 10.1080/02770900801890372.
The aim of this study was to explore possible interactions between a glucocorticosteroid (budesonide) and a long-acting beta(2)-agonist (formoterol) on pro-inflammatory cytokine release. Primary bronchial epithelial cells (PBEC) were stimulated with organic dust and incubated with budesonide, formoterol, and the combination of both drugs. Interleukin (IL)-6 and -8 in the supernatant was assessed by enzyme-linked immunosorbent assay (ELISA). Formoterol increased the IL-6 release but did not influence the IL-8 release. Budesonide attenuated the IL-6 and IL-8 release, an inhibiting effect that was sustained, but not reinforced, by formoterol.
本研究的目的是探讨糖皮质激素(布地奈德)与长效β₂受体激动剂(福莫特罗)在促炎细胞因子释放方面可能存在的相互作用。用有机粉尘刺激原代支气管上皮细胞(PBEC),并使其与布地奈德、福莫特罗以及两种药物的组合一起孵育。通过酶联免疫吸附测定(ELISA)评估上清液中的白细胞介素(IL)-6和IL-8。福莫特罗增加了IL-6的释放,但不影响IL-8的释放。布地奈德减弱了IL-6和IL-8的释放,福莫特罗维持了这种抑制作用,但并未增强该作用。